Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.

Mol Pharmacol

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (A.A., T.C.M., L.V., S.R.F., H.B.-O.); Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia (S.D.H., K.J.G.); and Cardiovascular Research, Novo Nordisk A/S, Novo Nordisk Park 1, Måløv, Denmark (J.L.H.)

Published: May 2021

Positive allosteric modulation of metabotropic glutamate subtype 5 (mGlu) receptor has emerged as a potential new therapeutic strategy for the treatment of schizophrenia and cognitive impairments. However, positive allosteric modulator (PAM) agonist activity has been associated with adverse side effects, and neurotoxicity has also been observed for pure PAMs. The structural and pharmacological basis of therapeutic versus adverse mGlu PAM in vivo effects remains unknown. Thus, gaining insights into the signaling fingerprints, as well as the binding kinetics of structurally diverse mGlu PAMs, may help in the rational design of compounds with desired properties. We assessed the binding and signaling profiles of -methyl-5-(phenylethynyl)pyrimidin-2-amine (MPPA), 3-cyano--(2,5-diphenylpyrazol-3-yl)benzamide (CDPPB), and 1-[4-(4-chloro-2-fluoro-phenyl)piperazin-1-yl]-2-(4-pyridylmethoxy)ethenone [compound 2c, a close analog of 1-(4-(2-chloro-4-fluorophenyl)piperazin-1-yl)-2-(pyridin-4-ylmethoxy)ethanone] in human embryonic kidney 293A cells stably expressing mGlu using Ca mobilization, inositol monophosphate (IP) accumulation, extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation, and receptor internalization assays. Of the three allosteric ligands, only CDPPB had intrinsic agonist efficacy, and it also had the longest receptor residence time and highest affinity. MPPA was a biased PAM, showing higher positive cooperativity with orthosteric agonists in ERK1/2 phosphorylation and Ca mobilization over IP accumulation and receptor internalization. In primary cortical neurons, all three PAMs showed stronger positive cooperativity with ()-3,5-dihydroxyphenylglycine (DHPG) in Ca mobilization over IP accumulation. Our characterization of three structurally diverse mGlu PAMs provides further molecular pharmacological insights and presents the first assessment of PAM-mediated mGlu internalization. SIGNIFICANCE STATEMENT: Enhancing metabotropic glutamate receptor subtype 5 (mGlu) activity is a promising strategy to treat cognitive and positive symptoms in schizophrenia. It is increasingly evident that positive allosteric modulators (PAMs) of mGlu are not all equal in preclinical models; there remains a need to better understand the molecular pharmacological properties of mGlu PAMs. This study reports detailed characterization of the binding and functional pharmacological properties of mGlu PAMs and is the first study of the effects of mGlu PAMs on receptor internalization.

Download full-text PDF

Source
http://dx.doi.org/10.1124/molpharm.120.000185DOI Listing

Publication Analysis

Top Keywords

mglu pams
20
positive allosteric
16
metabotropic glutamate
12
receptor internalization
12
mglu
11
allosteric modulators
8
glutamate receptor
8
subtype mglu
8
pams
8
structurally diverse
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!